 Peter Baker
Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Addison Disease | 5 | 2014 | 43 | 1.590 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 3 | 2021 | 24 | 1.490 |
Why?
| | Steroid 21-Hydroxylase | 4 | 2014 | 30 | 1.280 |
Why?
| | Metabolism, Inborn Errors | 3 | 2021 | 41 | 1.010 |
Why?
| | Ammonia | 1 | 2023 | 62 | 0.810 |
Why?
| | Adiposity | 2 | 2017 | 518 | 0.790 |
Why?
| | Glutathione | 1 | 2024 | 356 | 0.770 |
Why?
| | Autoantibodies | 6 | 2015 | 1496 | 0.770 |
Why?
| | Nutritional Status | 3 | 2023 | 350 | 0.740 |
Why?
| | Energy Metabolism | 3 | 2024 | 922 | 0.740 |
Why?
| | Methionine | 1 | 2021 | 160 | 0.690 |
Why?
| | Vitamin B 12 | 1 | 2021 | 128 | 0.690 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2023 | 201 | 0.680 |
Why?
| | Leukodystrophy, Globoid Cell | 1 | 2020 | 8 | 0.670 |
Why?
| | Isoleucine | 1 | 2020 | 15 | 0.660 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2020 | 46 | 0.640 |
Why?
| | Valine | 1 | 2020 | 82 | 0.640 |
Why?
| | Fetal Macrosomia | 1 | 2020 | 62 | 0.640 |
Why?
| | Obesity | 7 | 2018 | 2992 | 0.630 |
Why?
| | Amino Acids | 4 | 2020 | 497 | 0.620 |
Why?
| | Epilepsy | 1 | 2023 | 333 | 0.620 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.590 |
Why?
| | Dietary Supplements | 2 | 2020 | 561 | 0.590 |
Why?
| | Infant, Newborn, Diseases | 1 | 2020 | 113 | 0.580 |
Why?
| | Neonatal Screening | 1 | 2020 | 169 | 0.580 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2018 | 279 | 0.580 |
Why?
| | Mitochondria, Liver | 1 | 2018 | 73 | 0.580 |
Why?
| | Neuroimaging | 1 | 2020 | 259 | 0.570 |
Why?
| | Metabolomics | 3 | 2024 | 678 | 0.560 |
Why?
| | Kidney | 1 | 2024 | 1468 | 0.510 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 815 | 0.510 |
Why?
| | Liver | 2 | 2024 | 1943 | 0.500 |
Why?
| | Fatty Acids | 2 | 2017 | 443 | 0.480 |
Why?
| | Poland Syndrome | 1 | 2014 | 1 | 0.460 |
Why?
| | Oxidative Stress | 5 | 2024 | 1317 | 0.450 |
Why?
| | HLA-A2 Antigen | 1 | 2014 | 48 | 0.450 |
Why?
| | Birth Weight | 1 | 2017 | 516 | 0.440 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2014 | 81 | 0.440 |
Why?
| | HLA-B Antigens | 2 | 2011 | 62 | 0.440 |
Why?
| | Sequence Deletion | 1 | 2014 | 183 | 0.440 |
Why?
| | Acidosis, Lactic | 2 | 2024 | 46 | 0.430 |
Why?
| | Sulfurtransferases | 1 | 2013 | 10 | 0.430 |
Why?
| | Glutaredoxins | 1 | 2013 | 13 | 0.430 |
Why?
| | HLA-DR3 Antigen | 2 | 2012 | 80 | 0.430 |
Why?
| | Homocystinuria | 1 | 2014 | 71 | 0.430 |
Why?
| | Muscle, Skeletal | 4 | 2021 | 1724 | 0.410 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5757 | 0.410 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2013 | 51 | 0.410 |
Why?
| | Carnitine | 3 | 2020 | 84 | 0.400 |
Why?
| | Genetic Variation | 2 | 2019 | 991 | 0.400 |
Why?
| | Gene Expression | 1 | 2017 | 1502 | 0.390 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 860 | 0.390 |
Why?
| | Genetic Predisposition to Disease | 7 | 2015 | 2426 | 0.380 |
Why?
| | Ring Chromosomes | 1 | 2010 | 2 | 0.350 |
Why?
| | Endocrine Cells | 1 | 2010 | 7 | 0.340 |
Why?
| | Carrier Proteins | 1 | 2014 | 771 | 0.330 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 73 | 0.330 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2015 | 3715 | 0.330 |
Why?
| | Abnormalities, Multiple | 2 | 2018 | 189 | 0.330 |
Why?
| | Mosaicism | 1 | 2010 | 73 | 0.320 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2691 | 0.320 |
Why?
| | Haplotypes | 4 | 2012 | 494 | 0.310 |
Why?
| | Humans | 34 | 2024 | 137585 | 0.310 |
Why?
| | Lipid Metabolism | 3 | 2018 | 518 | 0.310 |
Why?
| | Infant | 10 | 2024 | 9465 | 0.310 |
Why?
| | Face | 1 | 2010 | 173 | 0.300 |
Why?
| | Male | 19 | 2024 | 67762 | 0.300 |
Why?
| | Autoimmunity | 2 | 2015 | 908 | 0.300 |
Why?
| | Fetus | 4 | 2021 | 806 | 0.290 |
Why?
| | Biomarkers | 5 | 2024 | 4149 | 0.290 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3566 | 0.280 |
Why?
| | Maternal Nutritional Physiological Phenomena | 3 | 2018 | 176 | 0.280 |
Why?
| | Pregnancy | 9 | 2021 | 6763 | 0.280 |
Why?
| | Proteins | 1 | 2013 | 1009 | 0.270 |
Why?
| | Infant, Newborn | 5 | 2024 | 6079 | 0.270 |
Why?
| | Mutation | 2 | 2018 | 3958 | 0.260 |
Why?
| | Female | 21 | 2021 | 73304 | 0.250 |
Why?
| | Glycosylation | 2 | 2023 | 151 | 0.240 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 8 | 0.230 |
Why?
| | HSP90 Heat-Shock Proteins | 1 | 2024 | 46 | 0.220 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.220 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.220 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 28 | 0.220 |
Why?
| | Transcription Factors, General | 1 | 2023 | 5 | 0.210 |
Why?
| | Niacinamide | 1 | 2024 | 82 | 0.210 |
Why?
| | Sheep | 3 | 2021 | 856 | 0.210 |
Why?
| | Keto Acids | 1 | 2023 | 13 | 0.210 |
Why?
| | HLA-DRB1 Chains | 2 | 2015 | 112 | 0.210 |
Why?
| | Mitochondria | 2 | 2021 | 948 | 0.200 |
Why?
| | Molecular Chaperones | 1 | 2024 | 195 | 0.200 |
Why?
| | Siblings | 1 | 2023 | 228 | 0.190 |
Why?
| | Glycolysis | 1 | 2024 | 321 | 0.190 |
Why?
| | HLA-B15 Antigen | 2 | 2012 | 13 | 0.190 |
Why?
| | Pregnancy Complications | 2 | 2018 | 527 | 0.190 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 18 | 0.190 |
Why?
| | Placental Insufficiency | 2 | 2021 | 116 | 0.190 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2018 | 605 | 0.190 |
Why?
| | Protein Processing, Post-Translational | 1 | 2024 | 465 | 0.190 |
Why?
| | Intellectual Disability | 1 | 2023 | 165 | 0.180 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 60 | 0.180 |
Why?
| | HLA-B8 Antigen | 2 | 2012 | 14 | 0.180 |
Why?
| | Lactic Acid | 1 | 2023 | 305 | 0.180 |
Why?
| | Mutation, Missense | 1 | 2023 | 341 | 0.180 |
Why?
| | Metabolism | 1 | 2021 | 42 | 0.180 |
Why?
| | Adult | 10 | 2021 | 37929 | 0.180 |
Why?
| | Homocysteine | 1 | 2021 | 156 | 0.180 |
Why?
| | Genotype | 5 | 2015 | 1916 | 0.180 |
Why?
| | Ischemia | 1 | 2024 | 409 | 0.170 |
Why?
| | Metabolome | 1 | 2024 | 350 | 0.170 |
Why?
| | Neurodevelopmental Disorders | 1 | 2023 | 181 | 0.170 |
Why?
| | Early Diagnosis | 1 | 2021 | 242 | 0.170 |
Why?
| | Propionic Acidemia | 1 | 2020 | 3 | 0.170 |
Why?
| | Cardiomyopathies | 1 | 2024 | 350 | 0.170 |
Why?
| | Leucine | 1 | 2020 | 111 | 0.160 |
Why?
| | Proteomics | 3 | 2024 | 1111 | 0.160 |
Why?
| | False Positive Reactions | 1 | 2020 | 115 | 0.160 |
Why?
| | Albinism | 1 | 2019 | 3 | 0.160 |
Why?
| | Lysosomal Storage Diseases | 1 | 2019 | 5 | 0.160 |
Why?
| | Acids | 1 | 2019 | 18 | 0.160 |
Why?
| | Chloride Channels | 1 | 2019 | 35 | 0.160 |
Why?
| | Disease Progression | 2 | 2020 | 2757 | 0.150 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 565 | 0.150 |
Why?
| | Lysosomes | 1 | 2019 | 141 | 0.150 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2018 | 36 | 0.150 |
Why?
| | Glucose | 2 | 2021 | 1020 | 0.150 |
Why?
| | Dystroglycans | 1 | 2018 | 6 | 0.150 |
Why?
| | Qb-SNARE Proteins | 1 | 2018 | 6 | 0.150 |
Why?
| | Colorado | 2 | 2020 | 4565 | 0.150 |
Why?
| | Leptin | 2 | 2018 | 236 | 0.140 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 36 | 0.140 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 395 | 0.140 |
Why?
| | Preconception Care | 1 | 2018 | 43 | 0.140 |
Why?
| | Insulin | 3 | 2018 | 2409 | 0.140 |
Why?
| | Micronutrients | 1 | 2018 | 92 | 0.140 |
Why?
| | Enteral Nutrition | 1 | 2020 | 202 | 0.140 |
Why?
| | Muscle Cells | 1 | 2017 | 43 | 0.140 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 84 | 0.140 |
Why?
| | Electron Transport | 1 | 2017 | 115 | 0.140 |
Why?
| | Phenotype | 3 | 2023 | 3196 | 0.140 |
Why?
| | Maternal-Fetal Exchange | 1 | 2018 | 165 | 0.140 |
Why?
| | Lipids | 2 | 2021 | 672 | 0.130 |
Why?
| | Animals | 8 | 2024 | 36940 | 0.130 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 91 | 0.130 |
Why?
| | Cell Proliferation | 1 | 2024 | 2475 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 532 | 0.130 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 460 | 0.130 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2016 | 6 | 0.130 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2016 | 16 | 0.130 |
Why?
| | Disease Susceptibility | 1 | 2018 | 347 | 0.130 |
Why?
| | Thyroiditis, Autoimmune | 1 | 2015 | 15 | 0.120 |
Why?
| | Oxidation-Reduction | 2 | 2020 | 1060 | 0.120 |
Why?
| | Hyperlipidemias | 1 | 2016 | 120 | 0.120 |
Why?
| | Retinal Diseases | 1 | 2016 | 91 | 0.120 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 82 | 0.120 |
Why?
| | Adipogenesis | 1 | 2015 | 55 | 0.120 |
Why?
| | Lower Extremity | 1 | 2019 | 427 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2189 | 0.120 |
Why?
| | HLA-DP beta-Chains | 1 | 2015 | 86 | 0.120 |
Why?
| | Fetal Development | 1 | 2018 | 296 | 0.120 |
Why?
| | Pediatric Obesity | 2 | 2020 | 601 | 0.120 |
Why?
| | Body Mass Index | 3 | 2018 | 2389 | 0.110 |
Why?
| | Alleles | 3 | 2015 | 891 | 0.110 |
Why?
| | PPAR gamma | 1 | 2015 | 182 | 0.110 |
Why?
| | Postprandial Period | 1 | 2015 | 107 | 0.110 |
Why?
| | Milk, Human | 1 | 2016 | 158 | 0.110 |
Why?
| | Oxidoreductases | 1 | 2014 | 92 | 0.110 |
Why?
| | Fibroblasts | 1 | 2019 | 996 | 0.110 |
Why?
| | Risk Factors | 3 | 2018 | 10388 | 0.110 |
Why?
| | South Africa | 1 | 2014 | 222 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4295 | 0.110 |
Why?
| | Diet, High-Fat | 1 | 2015 | 247 | 0.100 |
Why?
| | Genetic Loci | 1 | 2015 | 288 | 0.100 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 660 | 0.100 |
Why?
| | beta Catenin | 1 | 2015 | 253 | 0.100 |
Why?
| | Atrophy | 1 | 2013 | 184 | 0.100 |
Why?
| | Longitudinal Studies | 2 | 2017 | 2844 | 0.100 |
Why?
| | Fatal Outcome | 1 | 2013 | 303 | 0.100 |
Why?
| | Cell Differentiation | 2 | 2017 | 1991 | 0.100 |
Why?
| | Child, Preschool | 2 | 2020 | 11074 | 0.100 |
Why?
| | Renin | 1 | 2012 | 35 | 0.100 |
Why?
| | HLA-DR4 Antigen | 1 | 2012 | 78 | 0.100 |
Why?
| | Mice | 3 | 2024 | 17787 | 0.090 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2012 | 143 | 0.090 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 257 | 0.090 |
Why?
| | Hypoxia | 1 | 2018 | 1112 | 0.090 |
Why?
| | Brain | 2 | 2020 | 2668 | 0.090 |
Why?
| | Dosage Compensation, Genetic | 1 | 2010 | 9 | 0.090 |
Why?
| | Major Histocompatibility Complex | 1 | 2011 | 227 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1774 | 0.080 |
Why?
| | HLA-DQ Antigens | 1 | 2011 | 181 | 0.080 |
Why?
| | Microarray Analysis | 1 | 2010 | 117 | 0.080 |
Why?
| | HLA-DR Antigens | 1 | 2011 | 228 | 0.080 |
Why?
| | Child | 4 | 2021 | 21935 | 0.080 |
Why?
| | Insulin Resistance | 1 | 2018 | 1208 | 0.080 |
Why?
| | Hydrocortisone | 1 | 2012 | 322 | 0.080 |
Why?
| | Linkage Disequilibrium | 1 | 2010 | 268 | 0.080 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 317 | 0.080 |
Why?
| | Apoptosis | 1 | 2018 | 2553 | 0.080 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 399 | 0.080 |
Why?
| | Pedigree | 1 | 2010 | 514 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 521 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 660 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2607 | 0.070 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 697 | 0.070 |
Why?
| | Treatment Outcome | 2 | 2020 | 10811 | 0.070 |
Why?
| | Developmental Disabilities | 1 | 2010 | 263 | 0.070 |
Why?
| | Risk | 1 | 2010 | 912 | 0.070 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 2031 | 0.060 |
Why?
| | Adolescent | 3 | 2015 | 21513 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2828 | 0.060 |
Why?
| | Time Factors | 2 | 2016 | 6828 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.060 |
Why?
| | Protein Interaction Maps | 1 | 2024 | 48 | 0.060 |
Why?
| | Serine | 1 | 2024 | 141 | 0.050 |
Why?
| | Zinc Fingers | 1 | 2023 | 50 | 0.050 |
Why?
| | Introns | 1 | 2024 | 258 | 0.050 |
Why?
| | Prognosis | 1 | 2012 | 4030 | 0.050 |
Why?
| | Genetic Association Studies | 2 | 2015 | 377 | 0.050 |
Why?
| | Young Adult | 3 | 2018 | 13209 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 343 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2012 | 5131 | 0.050 |
Why?
| | Retrospective Studies | 1 | 2020 | 15657 | 0.050 |
Why?
| | Echocardiography | 1 | 2024 | 642 | 0.040 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 37 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5472 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 193 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 155 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 218 | 0.040 |
Why?
| | Phosphorylation | 1 | 2024 | 1759 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 185 | 0.040 |
Why?
| | Drug Synergism | 1 | 2020 | 382 | 0.040 |
Why?
| | Xenopus laevis | 1 | 2019 | 106 | 0.040 |
Why?
| | Hindlimb | 1 | 2019 | 128 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 152 | 0.040 |
Why?
| | Macaca | 1 | 2018 | 56 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 57 | 0.040 |
Why?
| | Critical Illness | 1 | 2024 | 811 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 79 | 0.040 |
Why?
| | Information Storage and Retrieval | 1 | 2019 | 118 | 0.040 |
Why?
| | Oocytes | 1 | 2019 | 181 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 81 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2019 | 231 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2019 | 560 | 0.030 |
Why?
| | Guatemala | 1 | 2018 | 327 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 153 | 0.030 |
Why?
| | United States | 1 | 2014 | 14841 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3412 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Adiponectin | 1 | 2018 | 244 | 0.030 |
Why?
| | Fundus Oculi | 1 | 2016 | 65 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Lipoprotein Lipase | 1 | 2016 | 59 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 524 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 106 | 0.030 |
Why?
| | Middle Aged | 2 | 2015 | 33479 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 657 | 0.030 |
Why?
| | Fatty Acids, Volatile | 1 | 2016 | 56 | 0.030 |
Why?
| | Iodide Peroxidase | 1 | 2015 | 28 | 0.030 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2015 | 18 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2019 | 739 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 72 | 0.030 |
Why?
| | Remission Induction | 1 | 2016 | 288 | 0.030 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 46 | 0.030 |
Why?
| | Iron-Binding Proteins | 1 | 2015 | 44 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2015 | 85 | 0.030 |
Why?
| | Pancreatitis | 1 | 2016 | 134 | 0.030 |
Why?
| | Transcription Factors | 1 | 2023 | 1719 | 0.030 |
Why?
| | Cohort Studies | 2 | 2016 | 5742 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 910 | 0.030 |
Why?
| | CTLA-4 Antigen | 1 | 2015 | 99 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 750 | 0.030 |
Why?
| | Muscle Development | 1 | 2015 | 111 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2020 | 803 | 0.030 |
Why?
| | Software | 1 | 2019 | 665 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 849 | 0.030 |
Why?
| | Feces | 1 | 2016 | 484 | 0.020 |
Why?
| | Autoantigens | 1 | 2015 | 430 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1509 | 0.020 |
Why?
| | Breast Feeding | 1 | 2016 | 440 | 0.020 |
Why?
| | Body Composition | 1 | 2016 | 684 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4193 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 5079 | 0.020 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|